Table 2.

Baseline pancreatic neuroendocrine tumor patient demographics by race.

Demographic	Overall (n = 179)	African American/Black (n = 49)	White (n = 130)	P-value
Age at time of surgery, median (IQR)	60.3 (50.9–67.7)	57.2 (47.8–64.6)	62.3 (52.9–68.6)	0.009
Gender
Female	93 (52.0%)	34 (69.4%)	59 (45.4%)	0.004
Male	86 (48.0%)	15 (30.6%)	71 (54.6%)
BMI (mean +/−SD)	31.4 +/−8.2	31.7 +/−9.7	31.3 +/−7.7	0.812
Married	126 (70.4%)	25 (51.0%)	101 (77.7%)	0.004
Insurance type
Private	93 (50.0%)	25 (48.1%)	68 (50.7%)	0.953
Governmental	84 (45.2%)	23 (44.2%)	61 (45.5%)
Uninsured	4 (2.2%)	1 (1.9%)	3 (2.2%)
Distance to treating facility, median (miles, IQR)	78.5 (36.5–120.6)	88.9 (54.2–139.3)	73.9 (33.2–102.7)	0.078
Tumor size (cm, mean ± SD)	3.4 ± 2.8	4.1 ± 3.7	3.1 ± 2.4	0.031
Surgical margin status: involved	27 (15.3%)	8 (16.7%)	19 (14.7%)	0.9441
Differentiation: well	126 (71.2%)	33 (68.8%)	93 (72.1%)	0.840
Tumor grade: 1	80 (45.2%)	20 (41.7%)	60 (46.5%)	0.8122
Tumor grade: 2	57 (32.2%)	15 (31.3%)	42 (32.6%)
Tumor grade: unknown	40 (22.7%)	13 (27.6%)	27 (20.9%)
Functional PNET	24 (13.4%)	5 (10.2%)	19 (14.6%)	0.270
Metastatic disease	21 (11.7%)	7 (14.3%)	14 (10.8%)	0.332

Bold indicates statistical significance, P < 0.05.